Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Belgium-Based UCB Plans Gwinnett County, Georgia, Manufacturing Operations

04/01/2026
Belgium-based biopharmaceutical company UCB Inc. plans to establish operations in Gwinnett County, Georgia. The $2 billion project is expected to create 330 jobs.

The company’s new approximately 460,000-square-foot manufacturing facility will be located at Rowen and produce biologics primarily for the U.S. market.

“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States,” said Jean-Christophe Tellier, CEO of UCB. “By investing in Georgia, where our U.S. headquarters have been based for more than three decades, we are strengthening our biologics manufacturing capabilities, supporting our innovation pipeline, and creating high-quality jobs in a state that offers outstanding talent, a strong manufacturing tradition, and an ecosystem designed for sustainable, long-term success. This project is expected to generate approximately $5 billion in total economic impact, reflecting the broader value it will create for the region and its communities.”

Project Director EJane Caraway represented the Georgia Department of Economic Development’s (GDEcD) Global Commerce team on the project in partnership with Partnership Gwinnett, Metro Atlanta Chamber, Georgia Quick Start, and Georgia Power.

“For more than a century, UCB has been a leader in biopharmaceutical innovation,” noted GDEcD Commissioner Pat Wilson. “Georgia’s growing life sciences ecosystem and collaborative approach to economic development connect companies with world-class partners in research, education, logistics, and infrastructure. Together with our focus on being the Top State for Talent, it’s why innovators like UCB choose Georgia to advance discoveries from R&D to real-world impact.”

UCB develops and manufactures treatments for neurological and immunological conditions. The company conducts research, clinical development, and global commercialization of prescription medicines.

“UCB’s decision to locate their new manufacturing operation in Gwinnett County is a testament to the strength of our entire region to support the growth of the life sciences industry,” added Katie Kirkpatrick, President and CEO of the Metro Atlanta Chamber. “UCB’s innovation, talent, and strategic investment show that metro Atlanta is not just a hub for life sciences today, but a place where the breakthroughs of tomorrow are taking shape.”

“This announcement marks the shift from preparation to execution at Rowen,” added Rowen Foundation President and CEO Mason Ailstock. “Over the past several years we have focused on building the infrastructure, partnerships and vision necessary to support complex global projects. With UCB’s selection, that work will now translate into real investment, real jobs and real momentum for Georgians. We’re grateful to the Governor, the Georgia Department of Economic Development, the Gwinnett team, industry leaders, higher education partners and our neighbors for supporting our vision and the work that is to come.”

Exclusive Research